Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice

Objective: Recently, we have shown that Bezafibrate (BEZ), the pan-PPAR (peroxisome proliferator-activated receptor) activator, ameliorated diabetes in insulin deficient streptozotocin treated diabetic mice. In order to study whether BEZ can also improve glucose metabolism in a mouse model for fatty...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Andras Franko, Susanne Neschen, Jan Rozman, Birgit Rathkolb, Michaela Aichler, Annette Feuchtinger, Laura Brachthäuser, Frauke Neff, Marketa Kovarova, Eckhard Wolf, Helmut Fuchs, Hans-Ulrich Häring, Andreas Peter, Martin Hrabě de Angelis
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2017-03-01
coleção:	Molecular Metabolism
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2212877816302861
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!